Accessing Public Health Campaigns in Puerto Rico
GrantID: 64173
Grant Funding Amount Low: $275,000
Deadline: June 2, 2026
Grant Amount High: $275,000
Summary
Explore related grant categories to find additional funding opportunities aligned with this program:
Awards grants, Business & Commerce grants, Education grants, Financial Assistance grants, Health & Medical grants, Higher Education grants.
Grant Overview
Target Outcomes for Rare Disease Research in Puerto Rico
The Grants for Early-Stage Research on Rare Diseases program in Puerto Rico is designed to accelerate the development of treatments and therapies for rare conditions. The primary focus is on bridging the gap between scientific discovery and clinical application, ultimately improving outcomes for individuals affected by rare diseases. The Puerto Rico Department of Health, in collaboration with the Puerto Rico Science, Technology, and Research Trust, plays a crucial role in overseeing the grant program and ensuring its alignment with the island's healthcare priorities.
Priority Outcomes and Their Significance
Puerto Rico's unique demographic and geographic features, including its relatively small population and island economy, make it an ideal location for focused research initiatives. The grant program prioritizes outcomes that address the specific needs of the Puerto Rican population, such as research on rare genetic disorders that are prevalent in the island's communities. Additionally, the program emphasizes the importance of developing treatments and therapies that can be effectively delivered in Puerto Rico's healthcare system, which faces distinct challenges due to its island geography.
One of the key priority outcomes is the advancement of research on rare diseases that disproportionately affect the Puerto Rican population. For instance, research on conditions such as Gaucher disease, which has a higher prevalence in Puerto Rico compared to other parts of the United States, is a priority. By focusing on these areas, the grant program aims to improve health outcomes for individuals affected by rare diseases and to contribute to the development of targeted treatments.
The grant program also prioritizes research that leverages Puerto Rico's existing strengths in biomedical research and its connections to the broader U.S. research community. For example, collaborations between researchers at the University of Puerto Rico and institutions in other states, such as Louisiana and Maryland, can facilitate the sharing of resources and expertise, ultimately enhancing the quality and impact of research conducted in Puerto Rico.
Measuring Success and Impact
The success of the Grants for Early-Stage Research on Rare Diseases program in Puerto Rico will be measured by its ability to advance research on rare diseases, improve health outcomes for affected individuals, and contribute to the development of new treatments and therapies. The program's impact will be assessed through regular evaluations and progress reports, which will track metrics such as the number of research projects supported, the publication of research findings, and the translation of research into clinical applications.
Q: What are the primary outcomes that the Grants for Early-Stage Research on Rare Diseases program in Puerto Rico aims to achieve? A: The program prioritizes the advancement of research on rare diseases that disproportionately affect the Puerto Rican population, the development of treatments and therapies that can be effectively delivered in Puerto Rico's healthcare system, and the leveraging of existing strengths in biomedical research.
Q: How will the success of the grant program be measured? A: The program's success will be measured through regular evaluations and progress reports, which will track metrics such as the number of research projects supported, the publication of research findings, and the translation of research into clinical applications.
Q: Can researchers from other institutions outside of Puerto Rico collaborate with Puerto Rican researchers on grant projects? A: Yes, the grant program encourages collaborations between researchers at the University of Puerto Rico and institutions in other states, which can facilitate the sharing of resources and expertise.
Eligible Regions
Interests
Eligible Requirements
Related Grants
Grants to Support Investigator-Initiated Early-Phase Clinical Trials
The grant aims to accelerate the development of innovative treatments and diagnostic tools for heart...
TGP Grant ID:
64183
Grants for Researching Hemodynamic Basis of Cognitive Impairment
The grant to uncover novel insights into the pathogenesis of cognitive decline associated with white...
TGP Grant ID:
64187
Grants for Pilot Project Enhancing Utility and Usage of Common Fund Data Sets
The grant to unlock the full potential of Common Fund data sets, fostering innovation and collaborat...
TGP Grant ID:
64188
Grants to Support Investigator-Initiated Early-Phase Clinical Trials
Deadline :
2026-10-02
Funding Amount:
$0
The grant aims to accelerate the development of innovative treatments and diagnostic tools for heart, lung, blood, and sleep (HLBS) conditions. The pr...
TGP Grant ID:
64183
Grants for Researching Hemodynamic Basis of Cognitive Impairment
Deadline :
2024-10-04
Funding Amount:
$0
The grant to uncover novel insights into the pathogenesis of cognitive decline associated with white matter disease, potentially paving the way for in...
TGP Grant ID:
64187
Grants for Pilot Project Enhancing Utility and Usage of Common Fund Data Sets
Deadline :
2024-06-27
Funding Amount:
$0
The grant to unlock the full potential of Common Fund data sets, fostering innovation and collaboration among researchers. The grant aims to catalyze...
TGP Grant ID:
64188